Go Pro
NYSE:ELMD

Electromed (ELMD) Stock Price, News & Analysis

Electromed logo
$26.53 +0.18 (+0.68%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$26.52 -0.01 (-0.02%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Electromed Stock (NYSE:ELMD)

Advanced

Key Stats

Today's Range
$26.04
$26.81
50-Day Range
$26.15
$45.99
52-Week Range
$23.01
$47.40
Volume
141,419 shs
Average Volume
77,930 shs
Market Capitalization
$221.95 million
P/E Ratio
35.37
Dividend Yield
N/A
Price Target
$43.75
Consensus Rating
Moderate Buy

Company Overview

Electromed, Inc. is a medical device company that develops, manufactures and distributes airway clearance systems. Its principal product is the SmartVest Airway Clearance System, an external high-frequency chest wall oscillation device designed to help mobilize pulmonary secretions and improve airway clearance.

The company’s products are used in the management of respiratory conditions that may impair the body’s ability to clear mucus, including cystic fibrosis, bronchiectasis and certain neuromuscular disorders. Electromed primarily serves patients through healthcare providers, specialty pharmacies, distributors and insurance-supported home-care channels.

Electromed is headquartered in New Prague, Minnesota, and has focused on respiratory care since its founding in 1992. The company markets its products throughout the United States and also serves selected international markets through distribution arrangements.

AI Generated. May Contain Errors.

Electromed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

ELMD MarketRank™: 

Electromed scored higher than 50% of companies evaluated by MarketBeat, and ranked 548th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Electromed has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Electromed has a consensus price target of $43.75, representing about 64.9% upside from its current price of $26.53.

  • Amount of Analyst Coverage

    Electromed has only been the subject of 2 research reports in the past 90 days.

  • Read more about Electromed's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Electromed is 35.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.62.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Electromed is 35.37, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.80.

  • Price to Book Value per Share Ratio

    Electromed has a P/B Ratio of 5.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for ELMD.
  • Dividend Yield

    Electromed does not currently pay a dividend.

  • Dividend Growth

    Electromed does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Electromed this week, compared to 1 article on an average week.
  • Search Interest

    6 people have searched for ELMD on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Electromed to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Electromed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.50% of the stock of Electromed is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    40.82% of the stock of Electromed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Electromed's insider trading history.
Receive ELMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Electromed and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ELMD Stock News Headlines

My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel
Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript
See More Headlines

ELMD Stock Analysis - Frequently Asked Questions

Electromed's stock was trading at $29.12 at the start of the year. Since then, ELMD stock has decreased by 8.9% and is now trading at $26.53.

Electromed, Inc. (NYSE:ELMD) posted its quarterly earnings data on Tuesday, November, 12th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.03 by $0.13. The firm had revenue of $14.67 million for the quarter. Electromed had a trailing twelve-month return on equity of 15.71% and a net margin of 11.34%.

Electromed's Board of Directors approved a stock buyback plan on Monday, March 10th 2025, which authorizes the company to repurchase $5,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 2.4% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's leadership believes its shares are undervalued.

Electromed (ELMD) raised $10 million in an initial public offering (IPO) on the week of October 3rd 2011. The company issued 2,000,000 shares at a price of $4.00-$6.00 per share.

Top institutional investors of Electromed include BlackRock Inc. (5.62%), Punch & Associates Investment Management Inc. (2.64%), Bank of New York Mellon Corp (0.56%) and Man Group plc (0.46%). Insiders that own company stock include James L Cunniff, Bradley M Nagel and Andrew Summers.
View institutional ownership trends
.

Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Electromed investors own include NVIDIA (NVDA), Enterprise Products Partners (EPD), Energy Transfer (ET), Meta Platforms (META), Pfizer (PFE), TransEnterix (TRXDW) and Avino Silver & Gold Mines (ASM).

Company Calendar

Last Earnings
11/12/2024
Today
9/18/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSE:ELMD
CIK
1488917
Employees
197
Year Founded
1992

Price Target and Rating

High Price Target
$50.00
Low Price Target
$38.00
Potential Upside/Downside
+64.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.31
Trailing P/E Ratio
35.37
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$5.15 million
Net Margins
11.34%
Pretax Margin
15.57%
Return on Equity
15.71%
Return on Assets
13.37%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.10
Quick Ratio
4.74

Sales & Book Value

Annual Sales
$73.78 million
Price / Sales
3.01
Cash Flow
$0.64 per share
Price / Cash Flow
41.36
Book Value
$5.10 per share
Price / Book
5.20

Miscellaneous

Outstanding Shares
8,366,000
Free Float
7,359,000
Market Cap
$221.95 million
Optionable
Optionable
Beta
0.46

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NYSE:ELMD) was last updated on 9/19/2026 by MarketBeat.com Staff.
From Our Partners